Skip to Main Content

Paper Details

Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.
Clin Cancer Res
100
2017
5-Azacitidine, 5-azacitidine, Advanced Breast Cancer, Cancer, DNA methyltransferase, ER, Entinostat, Patients, TNBC, breast cancer, entinostat, estrogen, estrogen receptor, genes, histone deacetylase, hormone-resistant or triple-negative breast cancer, patients, tumor, tumor samples, women
Author NameAffiliation
Antonio C WolffSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Peter W LairdVan Andel Research Institute
Peter W LairdVan Andel Research Institute
Hui ShenVan Andel Research Institute
Hui ShenVan Andel Research Institute
Daniel J WeisenbergerUniversity of Southern California
Leslie CopeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Stephen B BaylinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Stephen B BaylinSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
Nancy E DavidsonUniversity of Pittsburgh Cancer Institute
Vered StearnsSidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine
  • 1 - 11

Datasets

Release 1.2